Log in

McKesson Stock Forecast, Price & News

+0.50 (+0.28 %)
(As of 11/27/2020 12:00 AM ET)
Today's Range
Now: $180.00
50-Day Range
MA: $163.20
52-Week Range
Now: $180.00
Volume469,445 shs
Average Volume2.35 million shs
Market Capitalization$28.90 billion
P/E Ratio13.70
Dividend Yield0.94%
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and solutions for life sciences companies, including offering multiple distribution channels and clinical trial access to specific patient populations through its network of oncology physicians. The segment also sells financial, operational and clinical solutions to pharmacies; and offers consulting, outsourcing, and other services. The Prescription Technology Solutions segment operates in the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. The International segment provides drug distribution services, specialty pharmacy, and retail and infusion care services. The Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Read More
McKesson logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 3.1Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.28 out of 5 stars

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors



Sales & Book Value

Annual Sales$231.05 billion
Cash Flow$23.14 per share
Book Value$37.55 per share


Net Income$900 million


Market Cap$28.90 billion
Next Earnings Date2/2/2021 (Estimated)
+0.50 (+0.28 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

McKesson (NYSE:MCK) Frequently Asked Questions

How has McKesson's stock been impacted by COVID-19 (Coronavirus)?

McKesson's stock was trading at $135.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MCK stock has increased by 33.2% and is now trading at $180.00.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of McKesson?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 2 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for McKesson
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than McKesson?

Wall Street analysts have given McKesson a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but McKesson wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for McKesson

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) released its quarterly earnings results on Sunday, November, 8th. The company reported $4.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.87 by $0.93. The business had revenue of $60.81 billion for the quarter, compared to analyst estimates of $59.35 billion. McKesson had a return on equity of 45.52% and a net margin of 0.95%. The firm's revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.60 EPS.
View McKesson's earnings history

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Thursday, October 29th. Shareholders of record on Tuesday, December 1st will be paid a dividend of $0.42 per share on Monday, January 4th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 0.93%. The ex-dividend date is Monday, November 30th.
View McKesson's dividend history

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY21 earnings guidance on Tuesday, November, 3rd. The company provided earnings per share (EPS) guidance of $16.00-16.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $15.18.

What price target have analysts set for MCK?

13 Wall Street analysts have issued twelve-month price objectives for McKesson's stock. Their forecasts range from $165.00 to $222.00. On average, they expect McKesson's stock price to reach $185.62 in the next twelve months. This suggests a possible upside of 3.1% from the stock's current price.
View analysts' price targets for McKesson

Are investors shorting McKesson?

McKesson saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 1,840,000 shares, a decline of 12.8% from the September 30th total of 2,110,000 shares. Based on an average trading volume of 1,060,000 shares, the short-interest ratio is currently 1.7 days. Approximately 1.1% of the company's stock are sold short.
View McKesson's Short Interest

Who are some of McKesson's key competitors?

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include The Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and The Home Depot (HD).

Who are McKesson's key executives?

McKesson's management team includes the following people:
  • Mr. Brian S. Tyler, CEO & Director (Age 53, Pay $5.56M)
  • Mr. Britt J. Vitalone, Exec. VP & CFO (Age 51, Pay $2.3M)
  • Ms. Lori A. Schechter, Exec. VP, Chief Legal Officer & Gen. Counsel (Age 58, Pay $2.71M)
  • Ms. Tracy L. Faber, Exec. VP & Chief HR Officer (Age 50, Pay $1.26M)
  • Mr. Sundeep G. Reddy, Sr. VP, Principal Accounting Officer & Corp. Controller (Age 46)
  • Ms. Nancy Flores, Exec. VP, Chief Information Officer & CTO (Age 53)
  • Ms. Holly Weiss, Sr. VP of Investor Relations
  • Mr. Pete Slone, Sr. VP of Corp. Public Affairs
  • Mr. Kirk Kaminsky, Pres of The US Pharmaceutical & Specialty Solutions Bus.
  • Paul A. Smith, Sr. VP of Taxes

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.95%), State Street Corp (4.71%), Massachusetts Financial Services Co. MA (3.68%), JPMorgan Chase & Co. (3.51%), Boston Partners (2.10%) and Pzena Investment Management LLC (2.06%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles and Sundeep G Reddy.
View institutional ownership trends for McKesson

Which institutional investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, AJO LP, BNP Paribas Arbitrage SA, CI Investments Inc., Nuveen Asset Management LLC, BNP PARIBAS ASSET MANAGEMENT Holding S.A., Charles Schwab Investment Management Inc., and Brandes Investment Partners LP. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Marie L/Ca Knowles, and Sundeep G Reddy.
View insider buying and selling activity for McKesson

Which institutional investors are buying McKesson stock?

MCK stock was purchased by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Pzena Investment Management LLC, JPMorgan Chase & Co., Jupiter Asset Management Ltd., Morgan Stanley, O Shaughnessy Asset Management LLC, Clough Capital Partners L P, and BlackRock Inc..
View insider buying and selling activity for McKesson

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $180.00.

How big of a company is McKesson?

McKesson has a market capitalization of $28.90 billion and generates $231.05 billion in revenue each year. The company earns $900 million in net income (profit) each year or $14.95 on an earnings per share basis. McKesson employs 60,000 workers across the globe.

What is McKesson's official website?

The official website for McKesson is www.mckesson.com.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.